Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients
- PMID: 32892371
- DOI: 10.1111/odi.13639
Transcriptomic analysis of peripheral blood mononuclear cells in head and neck squamous cell carcinoma patients
Abstract
Objectives: To investigate the gene expression profile of peripheral blood mononuclear cells (PBMCs) from head and neck squamous cell carcinoma (HNSCC), including oral cancer (OC) and oropharyngeal cancer (OPC) patients, and compare them with healthy controls (HC).
Materials and methods: Transcriptomic analysis of PBMCs was performed by RNA-sequencing. The upregulated candidate genes were selected for validation by quantitative real-time polymerase chain reaction (qPCR). In addition, related plasma protein levels were determined by enzyme-linked immunosorbent assay (ELISA).
Results: Three significantly upregulated genes, including high mobility group nucleosomal binding domain 2 (HMGN2), folate receptor gamma (FOLR3), and amphiregulin (AREG), were selected. In the first cohort, the results showed that only HMGN2 expression was significantly increased in OC patients. In the larger sample size, the overall results demonstrated that HMGN2 expression had a tendency to increase in both OC and OPC patients compared with HC. Interestingly, the plasma HMGN2 (HMG-17) protein level exhibited the same trend as that observed at the transcriptional level.
Conclusion: HMGN2 expression and plasma HMG-17 (HMGN2 protein) were increased in both cancer patients compared with HC. This gene may be important for further functional studies in the PBMCs of HNSCC patients.
Keywords: HMGN2; RNA-sequencing; head and neck squamous cell carcinoma; peripheral blood mononuclear cells; transcriptome.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.
Similar articles
-
Induction of ZCCHC6 expression in peripheral blood mononuclear cells by HNSCC secretions.Gene. 2020 Sep 5;754:144880. doi: 10.1016/j.gene.2020.144880. Epub 2020 Jun 9. Gene. 2020. PMID: 32526260
-
Head and neck squamous cell carcinoma drives long interspersed element-1 hypomethylation in the peripheral blood mononuclear cells.Oral Dis. 2019 Jan;25(1):64-72. doi: 10.1111/odi.12944. Epub 2018 Aug 20. Oral Dis. 2019. PMID: 30047194
-
HMGN2: An Antitumor Effector Molecule of γδT Cells.J Immunother. 2018 Apr;41(3):118-124. doi: 10.1097/CJI.0000000000000211. J Immunother. 2018. PMID: 29401165
-
High 4-1BB Expression in PBMCs and Tumor Infiltrating Lymphocytes (TILs) in Patients with Head and Neck Squamous Cell Carcinoma.Eur J Dent. 2023 May 2. doi: 10.1055/s-0043-1764419. Online ahead of print. Eur J Dent. 2023. PMID: 37130554
-
Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.Neurosurg Focus. 2018 Jun;44(6):E11. doi: 10.3171/2018.2.FOCUS17761. Neurosurg Focus. 2018. PMID: 29852772 Review.
Cited by
-
Signatures and prognostic values of related immune targets in tongue cancer.Front Surg. 2023 Jan 4;9:952389. doi: 10.3389/fsurg.2022.952389. eCollection 2022. Front Surg. 2023. PMID: 36684241 Free PMC article.
References
REFERENCES
-
- Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., … Winchester, D. P. (Eds). (2017). AJCC cancer staging manual. New York City: Springer International Publishing.
-
- Andrews, S., Gilley, J., & Coleman, M. P. (2010). Difference Tracker: ImageJ plugins for fully automated analysis of multiple axonal transport parameters. Journal of neuroscience methods, 193(2), 281-287. https://doi.org/10.1016/j.jneumeth.2010.09.007
-
- Arayataweegool, A., Srisuttee, R., Mahattanasakul, P., Tangjaturonsasme, N., Kerekhanjanarong, V., Kitkumthorn, N., & Mutirangura, A. (2019). Head and neck squamous cell carcinoma drives long interspersed element-1 hypomethylation in the peripheral blood mononuclear cells. Oral Diseases, 25(1), 64-72. https://doi.org/10.1111/odi.12944
-
- Assaraf, Y. G., Leamon, C. P., & Reddy, J. A. (2014). The folate receptor as a rational therapeutic target for personalized cancer treatment. Drug Resistance Updates, 17(4-6), 89-95. https://doi.org/10.1016/j.drup.2014.10.002
-
- Boonsongserm, P., Angsuwatcharakon, P., Puttipanyalears, C., Aporntewan, C., Kongruttanachok, N., Aksornkitti, V., … Mutirangura, A. (2019). Tumor-induced DNA methylation in the white blood cells of patients with colorectal cancer. Oncology Letters, 18(3), 3039-3048. https://doi.org/10.3892/ol.2019.10638
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
